The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
AbbVie will offer reduced prices for its medicines in Medicaid and commit $100 billion over the next decade to US research, development and capital investments, including domestic manufacturing
The clearance marks a major step in Diabeloop’s ambition to become a central partner for insulin pump manufacturers and expand access to automated insulin delivery in the US market
The agreement responds directly to President Trump’s demands that drugmakers cut costs for US patients
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
The approval is backed by data showing deep, durable responses and manageable tolerability
The approval introduces a needle-free alternative to injectable GLP-1 therapies
The company is pursuing the accelerated FDA 505(b)(2) approval pathway for its once-daily oral ondansetron formulation
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
Subscribe To Our Newsletter & Stay Updated
